** Medical device maker's shares CFMS.O rise 9.8% to $1.07
** Reaches settlement with Zimmer Biomet ZBH.N to resolve
patent dispute
** Says in regulatory filing that settlement requires ZBH to
pay a total of $9.6 mln [https://bit.ly/2TOjHNZ
]
** Both cos have dismissed all outstanding litigation tied
to their offerings, including knee and hip replacement products
** Both have also cross-licensed their technologies
** Brokerage Cowen & Co says encouraged by CFMS's ability to
protect and monetize IP
** Adds that latest settlement comparable to patent dispute
resolution reached with SNN in Sept. 2018 when CFMS got $10.5
mln and both settlements validate strength of CFMS's IP
** CFMS has been able to cut its quarterly cash burn to a
rate of ~$5 mln/qtr and additional $9.5 mln in non-dilutive
capital extends co's runway - Cowen
** Stock down ~29% YTD
(Reporting by Mrinalika roy in Bengaluru)
((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))